Shen W, Düren M, Morita E, Higgins C, Duh Q Y, Siperstein A E, Clark O H
Department of Surgery, University of California, San Francisco/Mt Zion Medical Center, USA.
Arch Surg. 1996 Aug;131(8):861-7; discussion 867-9. doi: 10.1001/archsurg.1996.01430200071013.
To analyze the causes and outcomes of reoperation for persistent or recurrent primary hyperparathyroidism.
Medical records of 102 patients with persistent or recurrent primary hyperparathyroidism who underwent reoperation by 1 surgeon between 1985 and 1995.
Only patients with persistent or recurrent primary hyperparathyroidism were selected; patients with secondary hyperparathyroidism, parathyroid cancer, familial hyperparathyroidism, and previous thyroid operations were omitted.
Performed by a single unblinded researcher.
Reasons for failed parathyroid operations included tumor in ectopic position (53%), incomplete resection of multiple abnormal glands (37%), adenoma in normal position missed during previous surgery (7%), and regrowth of previously resected tumor (3%). Of the ectopic glands, 28% were paraesophageal, 26% in the mediastinum (nonthymic), 24% intrathymic, 11% intrathyroidal, 9% in the carotid sheath, and 2% in a high cervical position. Eighty-three percent of ectopic glands were accessible via cervical incision. The success rate of reoperations was 95%. One patient (1%) became permanently hypocalcemic after reoperation; 1 patient (1%) suffered permanent unilateral vocal cord paralysis. The sensitivities of preoperative localization studies were as follows: technetium Tc 99m sestamibi scan, 77%; magnetic resonance imaging, 77%; selective venous catheterization for intact parathyroid hormone, 77%; thallium-technetium scan, 68%; ultrasonography, 57%; and computed tomography, 42%.
Repeated parathyroidectomy can be avoided in more than 95% of patients if an experienced surgeon performs bilateral cervical exploration during the initial parathyroid operation. For patients with persistent or recurrent primary hyperparathyroidism, preoperative localization studies and a focused surgical approach can result in a 95% success rate with minimum complications.
分析持续性或复发性原发性甲状旁腺功能亢进再次手术的原因及结果。
1985年至1995年间由1名外科医生对102例持续性或复发性原发性甲状旁腺功能亢进患者进行再次手术的病历资料。
仅选择持续性或复发性原发性甲状旁腺功能亢进患者;排除继发性甲状旁腺功能亢进、甲状旁腺癌、家族性甲状旁腺功能亢进及既往有甲状腺手术史的患者。
由一名未设盲的研究人员进行。
甲状旁腺手术失败的原因包括异位肿瘤(53%)、多个异常腺体切除不完全(37%)、既往手术遗漏正常位置的腺瘤(7%)以及先前切除肿瘤的再生(3%)。异位腺体中,28%位于食管旁,26%位于纵隔(非胸腺),24%位于胸腺内,11%位于甲状腺内,9%位于颈动脉鞘内,2%位于高位颈椎。83%的异位腺体可通过颈部切口显露。再次手术的成功率为95%。1例患者(1%)再次手术后发生永久性低钙血症;1例患者(1%)出现永久性单侧声带麻痹。术前定位检查的敏感性如下:锝Tc 99m甲氧基异丁基异腈扫描为77%;磁共振成像为77%;选择性静脉插管测定完整甲状旁腺激素为77%;铊-锝扫描为68%;超声检查为57%;计算机断层扫描为42%。
如果经验丰富的外科医生在初次甲状旁腺手术时进行双侧颈部探查,超过95%的患者可避免再次进行甲状旁腺切除术。对于持续性或复发性原发性甲状旁腺功能亢进患者,术前定位检查和有针对性的手术方法可使成功率达到95%,且并发症最少。